Table 1 Summary of Studies used to estimate the Risk of Parkinson’s Disease among the Patients with Gout
From: Risk of Parkinson’s disease following gout: a population-based retrospective cohort study in Taiwan
Study | Year | Study Design | Ethnic Group (Country) | Risk Ratio (95% CIa) |
|---|---|---|---|---|
Alonso et al. | 2007 | Case-control | Europe (United Kingdom) | 0.69 (0.48–0.99) |
De Vera et al. | 2008 | Retrospective cohort | North America (Canada) | 0.70 (0.59–0.83) |
Schernhammer et al. | 2013 | Case-control | Europe (Denmark) | 1.06 (0.90–1.25) |
Lai et al. | 2014 | Case-control | Asia (Taiwan) | 1.00 (0.90–1.11) |
Pakpoor et al. | 2015 | Retrospective cohort | Europe (United Kingdom) | 1.11 (1.05–1.17) |
The present study | 2020 | Retrospective cohort | Asia (Taiwan) | 1.01 (0.93–1.31) |